Annual Long Term Debt
$205.21 M
-$5.48 M-2.60%
31 December 2023
Summary:
Core Laboratories NV annual long term debt is currently $205.21 million, with the most recent change of -$5.48 million (-2.60%) on 31 December 2023. During the last 3 years, it has fallen by -$110.33 million (-34.97%). CLB annual long term debt is now -52.39% below its all-time high of $430.99 million, reached on 31 December 2015.CLB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$183.60 M
-$6.64 M-3.49%
30 September 2024
Summary:
Core Laboratories NV quarterly long term debt is currently $183.60 million, with the most recent change of -$6.64 million (-3.49%) on 30 September 2024. Over the past year, it has dropped by -$35.17 million (-16.08%). CLB quarterly long term debt is now -57.40% below its all-time high of $430.99 million, reached on 31 December 2015.CLB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.6% | -16.1% |
3 y3 years | -35.0% | -24.2% |
5 y5 years | -29.2% | -49.1% |
CLB Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -35.0% | at low | -24.2% | at low |
5 y | 5 years | -44.5% | at low | -50.4% | at low |
alltime | all time | -52.4% | +2215.1% | -57.4% | +8310.4% |
Core Laboratories NV Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $183.60 M(-3.5%) |
June 2024 | - | $190.24 M(-5.8%) |
Mar 2024 | - | $201.85 M(-1.6%) |
Dec 2023 | $205.21 M(-2.6%) | $205.21 M(-6.2%) |
Sept 2023 | - | $218.77 M(-2.8%) |
June 2023 | - | $224.96 M(+0.3%) |
Mar 2023 | - | $224.23 M(+6.4%) |
Dec 2022 | $210.69 M(-11.4%) | $210.69 M(-6.2%) |
Sept 2022 | - | $224.65 M(-2.8%) |
June 2022 | - | $231.21 M(-2.3%) |
Mar 2022 | - | $236.69 M(-0.5%) |
Dec 2021 | $237.92 M(-24.6%) | $237.92 M(-1.8%) |
Sept 2021 | - | $242.29 M(-8.0%) |
June 2021 | - | $263.43 M(-1.3%) |
Mar 2021 | - | $266.80 M(-15.4%) |
Dec 2020 | $315.54 M(-14.7%) | $315.54 M(+28.2%) |
Sept 2020 | - | $246.22 M(-28.4%) |
June 2020 | - | $344.06 M(-5.1%) |
Mar 2020 | - | $362.58 M(-2.0%) |
Dec 2019 | $369.94 M(+27.7%) | $369.94 M(+2.5%) |
Sept 2019 | - | $360.90 M(+2.3%) |
June 2019 | - | $352.76 M(-1.7%) |
Mar 2019 | - | $358.99 M(+23.9%) |
Dec 2018 | $289.77 M(+27.7%) | $289.77 M(-2.0%) |
Sept 2018 | - | $295.75 M(+22.4%) |
June 2018 | - | $241.69 M(+2.8%) |
Mar 2018 | - | $235.11 M(+3.6%) |
Dec 2017 | $226.99 M(+4.9%) | $226.99 M(-2.9%) |
Sept 2017 | - | $233.86 M(+0.1%) |
June 2017 | - | $233.74 M(+6.9%) |
Mar 2017 | - | $218.61 M(+1.0%) |
Dec 2016 | $216.49 M(-49.8%) | $216.49 M(+4.9%) |
Sept 2016 | - | $206.36 M(-0.9%) |
June 2016 | - | $208.24 M(-48.9%) |
Mar 2016 | - | $407.11 M(-5.5%) |
Dec 2015 | $430.99 M(+21.9%) | $430.99 M(+0.7%) |
Sept 2015 | - | $428.00 M(+1.5%) |
June 2015 | - | $421.51 M(+13.0%) |
Mar 2015 | - | $373.00 M(+5.5%) |
Dec 2014 | $353.67 M(+32.5%) | $353.67 M(-4.4%) |
Sept 2014 | - | $370.00 M(+11.1%) |
June 2014 | - | $333.00 M(+19.4%) |
Mar 2014 | - | $279.00 M(+4.5%) |
Dec 2013 | $267.00 M(+14.1%) | $267.00 M(+4.3%) |
Sept 2013 | - | $256.01 M(+2.4%) |
June 2013 | - | $250.01 M(+3.7%) |
Mar 2013 | - | $241.02 M(+3.0%) |
Dec 2012 | $234.03 M(+4.9%) | $234.03 M(+9.9%) |
Sept 2012 | - | $213.04 M(+3.4%) |
June 2012 | - | $206.05 M(+4.0%) |
Mar 2012 | - | $198.07 M(-11.2%) |
Dec 2011 | $223.07 M(+2416.6%) | $223.07 M(+43.4%) |
Sept 2011 | - | $155.60 M(+7027.9%) |
June 2011 | - | $2.18 M(-51.7%) |
Mar 2011 | - | $4.52 M(-49.0%) |
Dec 2010 | $8.86 M | $8.86 M(-44.9%) |
Sept 2010 | - | $16.10 M(-26.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | $21.87 M(-89.5%) |
Dec 2009 | $209.11 M(+7.5%) | $209.11 M(+1.8%) |
Sept 2009 | - | $205.38 M(+1.8%) |
June 2009 | - | $201.71 M(+1.8%) |
Mar 2009 | - | $198.11 M(+1.8%) |
Dec 2008 | $194.57 M(-35.1%) | $194.57 M(-35.1%) |
Sept 2008 | - | $300.00 M(0.0%) |
Mar 2008 | - | $300.00 M(0.0%) |
Dec 2007 | $300.00 M(-0.0%) | $300.00 M(-0.0%) |
Sept 2007 | - | $300.00 M(-0.0%) |
June 2007 | - | $300.00 M(0.0%) |
Mar 2007 | - | $300.00 M(0.0%) |
Dec 2006 | $300.00 M(+248.4%) | $300.00 M(+180.4%) |
Sept 2006 | - | $107.00 M(+3.9%) |
June 2006 | - | $103.00 M(+13.1%) |
Mar 2006 | - | $91.10 M(+5.8%) |
Dec 2005 | $86.10 M(-21.9%) | $86.10 M(-4.4%) |
Sept 2005 | - | $90.11 M(-11.8%) |
June 2005 | - | $102.11 M(-9.0%) |
Mar 2005 | - | $112.22 M(+1.8%) |
Dec 2004 | $110.22 M(-11.6%) | $110.22 M(-6.1%) |
Sept 2004 | - | $117.33 M(-1.7%) |
June 2004 | - | $119.37 M(-4.9%) |
Mar 2004 | - | $125.56 M(+0.7%) |
Dec 2003 | $124.68 M(+41.6%) | $124.68 M(-0.8%) |
Sept 2003 | - | $125.64 M(+25.2%) |
June 2003 | - | $100.37 M(+9.1%) |
Mar 2003 | - | $92.02 M(+4.5%) |
Dec 2002 | $88.03 M(-7.4%) | $88.03 M(+0.0%) |
Sept 2002 | - | $88.00 M(-1.1%) |
June 2002 | - | $89.00 M(-5.3%) |
Mar 2002 | - | $94.00 M(-1.2%) |
Dec 2001 | $95.12 M(+14.5%) | $95.12 M(-2.7%) |
Sept 2001 | - | $97.71 M(+16.2%) |
June 2001 | - | $84.08 M(+6.4%) |
Mar 2001 | - | $79.00 M(-4.9%) |
Dec 2000 | $83.04 M(-2.3%) | $83.04 M(-3.9%) |
Sept 2000 | - | $86.45 M(+1.8%) |
June 2000 | - | $84.89 M(+9.7%) |
Mar 2000 | - | $77.38 M(-8.9%) |
Dec 1999 | $84.97 M(+25.5%) | $84.97 M(-19.3%) |
Sept 1999 | - | $105.30 M(+26.4%) |
June 1999 | - | $83.30 M(+22.1%) |
Mar 1999 | - | $68.20 M(+0.7%) |
Dec 1998 | $67.70 M(-4.6%) | $67.70 M(-7.8%) |
Sept 1998 | - | $73.40 M(+4.7%) |
June 1998 | - | $70.10 M(-0.8%) |
Mar 1998 | - | $70.70 M(-0.4%) |
Dec 1997 | $71.00 M(+512.1%) | $71.00 M(-36.6%) |
Sept 1997 | - | $111.90 M(+0.6%) |
June 1997 | - | $111.20 M(+284.8%) |
Mar 1997 | - | $28.90 M(+149.1%) |
Dec 1996 | $11.60 M(-2.5%) | $11.60 M(-2.5%) |
Sept 1996 | - | $11.90 M(-7.8%) |
June 1996 | - | $12.90 M(-7.2%) |
Mar 1996 | - | $13.90 M(+16.8%) |
Dec 1995 | $11.90 M | $11.90 M(+19.0%) |
Sept 1995 | - | $10.00 M |
FAQ
- What is Core Laboratories NV annual long term debt?
- What is the all time high annual long term debt for Core Laboratories NV?
- What is Core Laboratories NV annual long term debt year-on-year change?
- What is Core Laboratories NV quarterly long term debt?
- What is the all time high quarterly long term debt for Core Laboratories NV?
- What is Core Laboratories NV quarterly long term debt year-on-year change?
What is Core Laboratories NV annual long term debt?
The current annual long term debt of CLB is $205.21 M
What is the all time high annual long term debt for Core Laboratories NV?
Core Laboratories NV all-time high annual long term debt is $430.99 M
What is Core Laboratories NV annual long term debt year-on-year change?
Over the past year, CLB annual long term debt has changed by -$5.48 M (-2.60%)
What is Core Laboratories NV quarterly long term debt?
The current quarterly long term debt of CLB is $183.60 M
What is the all time high quarterly long term debt for Core Laboratories NV?
Core Laboratories NV all-time high quarterly long term debt is $430.99 M
What is Core Laboratories NV quarterly long term debt year-on-year change?
Over the past year, CLB quarterly long term debt has changed by -$35.17 M (-16.08%)